Publications
Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluid
Cancer Genetics, April 2025
Analytical Validation and Clinical Sensitivity of the Belay Summit assay for the detection of DNA variants in cerebrospinal fluid of primary and metastatic CNS cancer
The Journal of Molecular Diagnostics, April 2025
Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules
The Proceedings of the National Academy of Sciences, August 2023
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
ThNature Biotechnology, May 2021
Detection of low frequency DNA variants by targeted sequencing of the Watson and Crick strands
Nature Biotechnology, May 2021
Detection of tumor-derived DNA in cerbrospinal fluid of patients with primary tumors of the brain and spinal cord
The Proceedings of the National Academy of Sciences, August 2015
Detection of circulating tumor DNA in early- and late-stage human malignancies
Science Translational Medicine, February 2014
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
The Proceedings of the National Academy of Sciences, April 2013
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
Science, September 2011
Detection and quantification of rare mutations with massively parallel sequencing
The Proceedings of the National Academy of Sciences, June 2011
The genetic landscape of the childhood cancer medulloblastoma
Science, January 2011